Abstract
The role that expectancy plays in response in clinical trials involving ketamine has received little attention. We hypothesized that single dose intravenous ketamine protocols would be associated with increased immediate depressive symptom reduction relative to multiple dose protocols due to a trial design mediated expectation of rapid symptom change.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
